The president of Mexico, Andres Manuel Lopez Obrador, has said that the country is sticking to its plan to package domestically the Russian COVID-19 vaccine Sputnik V because health matters are separate from political conflicts, Reuters news agency reported on Wednesday.
In October 2021, state-run vaccine company Birmex had signed an agreement with the Russian Direct Investment Fund (RDIF), which markets Sputnik V, to package the product in Mexico.
The president speaking at a regular news conference said: "We're going to continue with our plan, commitments made are kept", adding, "Health has nothing to do with political conflicts."
Obrador has ruled out imposing economic sanctions against Russia for its invasion of Ukraine, Reuters added.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses